Chuvash polycythemia: genes and variants

Explore variant evidence for Chuvash polycythemia across 1 analyzed protein (VHL). Linked ClinVar records include 116 pathogenic or likely pathogenic variants, 287 variants of uncertain significance and 168 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.

Data updated 2026-11-05. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to Chuvash polycythemia

Where Chuvash polycythemia variants cluster

ClinVar pathogenic and likely pathogenic variants linked to Chuvash polycythemia

VariantPositionProtein partClinical label
VHL R82L82Pathogenic / likely pathogenic (★★)
VHL P86S86Pathogenic / likely pathogenic (★★)
VHL G93V93Pathogenic / likely pathogenic (★★)
VHL G93S93Pathogenic / likely pathogenic (★★)
VHL Y98H98Pathogenic / likely pathogenic (★★)
VHL R107H107Involved in binding to CCT complexPathogenic / likely pathogenic (★★)
VHL S111R111Involved in binding to CCT complexPathogenic / likely pathogenic (★★)
VHL Y112C112Involved in binding to CCT complexPathogenic / likely pathogenic (★★)
VHL D121G121Involved in binding to CCT complexPathogenic / likely pathogenic (★★)
VHL P154S154Involved in binding to CCT complexPathogenic / likely pathogenic (★★)
VHL R161Q161Interaction with Elongin BC complexPathogenic / likely pathogenic (★★)
VHL R167W167Pathogenic / likely pathogenic (★★)
VHL Y175C175Pathogenic / likely pathogenic (★★)
VHL S65L65Pathogenic / likely pathogenic (★★)
VHL N78T78Pathogenic / likely pathogenic (★★)
VHL N78D78Pathogenic / likely pathogenic (★★)
VHL S80R80Pathogenic / likely pathogenic (★★)
VHL S80G80Pathogenic / likely pathogenic (★★)
VHL S80N80Pathogenic / likely pathogenic (★★)
VHL S80I80Pathogenic / likely pathogenic (★★)
VHL V84M84Pathogenic / likely pathogenic (★★)
VHL P86R86Pathogenic / likely pathogenic (★★)
VHL P86A86Pathogenic / likely pathogenic (★★)
VHL W88R88Pathogenic / likely pathogenic (★★)
VHL G93D93Pathogenic / likely pathogenic (★★)
VHL G93R93Pathogenic / likely pathogenic (★★)
VHL Y98S98Pathogenic / likely pathogenic (★★)
VHL Y98C98Pathogenic / likely pathogenic (★★)
VHL R107P107Involved in binding to CCT complexPathogenic / likely pathogenic (★★)
VHL R107G107Involved in binding to CCT complexPathogenic / likely pathogenic (★★)
VHL S111G111Involved in binding to CCT complexPathogenic / likely pathogenic (★★)
VHL Y112N112Involved in binding to CCT complexPathogenic / likely pathogenic (★★)
VHL Y112S112Involved in binding to CCT complexPathogenic / likely pathogenic (★★)
VHL Y112H112Involved in binding to CCT complexPathogenic / likely pathogenic (★★)
VHL G114R114Involved in binding to CCT complexPathogenic / likely pathogenic (★★)
VHL G114S114Involved in binding to CCT complexPathogenic / likely pathogenic (★★)
VHL H115Q115Involved in binding to CCT complexPathogenic / likely pathogenic (★★)
VHL H115R115Involved in binding to CCT complexPathogenic / likely pathogenic (★★)
VHL N131K131Involved in binding to CCT complexPathogenic / likely pathogenic (★★)
VHL N131Y131Involved in binding to CCT complexPathogenic / likely pathogenic (★★)
VHL P154L154Involved in binding to CCT complexPathogenic / likely pathogenic (★★)
VHL V155M155Involved in binding to CCT complexPathogenic / likely pathogenic (★★)
VHL L158V158Interaction with Elongin BC complexPathogenic / likely pathogenic (★★)
VHL L158P158Interaction with Elongin BC complexPathogenic / likely pathogenic (★★)
VHL R161G161Interaction with Elongin BC complexPathogenic / likely pathogenic (★★)
VHL C162W162Interaction with Elongin BC complexPathogenic / likely pathogenic (★★)
VHL C162R162Interaction with Elongin BC complexPathogenic / likely pathogenic (★★)
VHL C162F162Interaction with Elongin BC complexPathogenic / likely pathogenic (★★)
VHL L163P163Interaction with Elongin BC complexPathogenic / likely pathogenic (★★)
VHL L163F163Interaction with Elongin BC complexPathogenic / likely pathogenic (★★)
VHL L163R163Interaction with Elongin BC complexPathogenic / likely pathogenic (★★)
VHL Q164H164Interaction with Elongin BC complexPathogenic / likely pathogenic (★★)
VHL Q164R164Interaction with Elongin BC complexPathogenic / likely pathogenic (★★)
VHL R167P167Pathogenic / likely pathogenic (★★)
VHL R167G167Pathogenic / likely pathogenic (★★)
VHL L188P188Pathogenic / likely pathogenic (★★)
VHL V84L84Pathogenic / likely pathogenic (★★)
VHL L101P101Involved in binding to CCT complexPathogenic / likely pathogenic (★★)
VHL S111N111Involved in binding to CCT complexPathogenic / likely pathogenic (★★)
VHL N131S131Involved in binding to CCT complexPathogenic / likely pathogenic (★★)

Showing 60 of 116.

Uncertain variants prioritized for review in Chuvash polycythemia

VariantPositionProtein partClinical labelEvidence
VHL R200W200Conflicting reports (★)+6: 3 other pathogenic changes within 3 positions; R200L at the same position is pathogenic; REVEL 0.867
VHL V130I130Involved in binding to CCT complexConflicting reports (★)+6: 6 other pathogenic changes within 3 positions; V130L at the same position is pathogenic; REVEL 0.824
VHL R64H64Conflicting reports (★)+6: 4 other pathogenic changes within 3 positions; R64S at the same position is pathogenic; REVEL 0.798
VHL I151V151Involved in binding to CCT complexConflicting reports (★)+6: 9 other pathogenic changes within 3 positions; I151T at the same position is pathogenic; REVEL 0.780
VHL R82C82Uncertain (★★)+6: 9 other pathogenic changes within 3 positions; R82G at the same position is pathogenic; REVEL 0.944
VHL F76C76Uncertain (★★)+6: 6 other pathogenic changes within 3 positions; F76Y at the same position is pathogenic; REVEL 0.917
VHL F136L136Involved in binding to CCT complexUncertain (★★)+6: 2 other pathogenic changes within 3 positions; F136V at the same position is pathogenic; REVEL 0.863
VHL V155A155Involved in binding to CCT complexUncertain (★★)+6: 10 other pathogenic changes within 3 positions; V155G at the same position is pathogenic; REVEL 0.850
VHL F76L76Uncertain (★★)+6: 6 other pathogenic changes within 3 positions; F76Y at the same position is pathogenic; REVEL 0.893

Which prediction tools work for Chuvash polycythemia

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Same protein, different disease

Diseases related to Chuvash polycythemia

Frequently asked questions

Which genes have records linked to Chuvash polycythemia?

This view contains 1 analyzed proteins: VHL. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 116 pathogenic or likely pathogenic variants, 287 variants of uncertain significance and 168 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 9 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 576 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center